These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10912964)

  • 61. An innovative test for non-invasive Kell genotyping on circulating fetal DNA by means of the allelic discrimination of K1 and K2 antigens.
    Cro' F; Lapucci C; Vicari E; Salsi G; Rizzo N; Farina A
    Am J Reprod Immunol; 2016 Dec; 76(6):499-503. PubMed ID: 27730708
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Implementation of routine screening for Kell antibodies: does it improve perinatal survival?
    Kamphuis MM; Lindenburg I; van Kamp IL; Meerman RH; Kanhai HH; Oepkes D
    Transfusion; 2008 May; 48(5):953-7. PubMed ID: 18248569
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Urinary estriol in Rh isoimmunization].
    Mello G; Curiel P
    Ann Ostet Ginecol Med Perinat; 1973 Jan; 94(1):44-53. PubMed ID: 4203391
    [No Abstract]   [Full Text] [Related]  

  • 64. [Blood group immunization: results of treatment of fetal anemia with intra-uterine intravascular blood transfusion in the Netherlands, 1987-1995].
    van Kamp IL; Klumper FJ; Meerman RH; Brand A; Bennebroek Gravenhorst J; Kanhai HH
    Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2527-31. PubMed ID: 10627756
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Haemolytic disease of the newborn--from a mother with anti-Kell, anti-E and anti-Vel anti-erythrocyte alloantibodies].
    Vućinović M; Jadrić H; Karelović D; Roje D; Haspl-Hundrić Z; Hrgović Z; Vućinović Z
    Z Geburtshilfe Neonatol; 2004 Oct; 208(5):197-202. PubMed ID: 15508054
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prospective non-invasive monitoring of pregnancies complicated by red cell alloimmunization.
    Iskaros J; Kingdom J; Morrison JJ; Rodeck C
    Ultrasound Obstet Gynecol; 1998 Jun; 11(6):432-7. PubMed ID: 9674091
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cytokines in fetal blood and amniotic fluid in Rh-immunized pregnancies.
    Westgren M; Ek S; Remberger M; Ringden O; Stangenberg M
    Obstet Gynecol; 1995 Aug; 86(2):209-13. PubMed ID: 7542377
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Reduction of anti-K-mediated hemolytic disease of newborns after the introduction of a matched transfusion policy: A nation-wide policy change evaluation study in the Netherlands.
    Luken JS; Folman CC; Lukens MV; Meekers JH; Ligthart PC; Schonewille H; Zwaginga JJ; Janssen MP; van der Schoot CE; van der Bom JG; de Haas M
    Transfusion; 2021 Mar; 61(3):713-721. PubMed ID: 33528025
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prenatal determination of genotypes Kell and Cellano in at-risk pregnancies.
    Spence WC; Maddalena A; Demers DB; Bick DP
    J Reprod Med; 1997 Jun; 42(6):353-7. PubMed ID: 9219123
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Management of isoimmunization in pregnancy. ACOG Technical Bulletin number 148--October 1990.
    Int J Gynaecol Obstet; 1992 Jan; 37(1):57-62. PubMed ID: 1346605
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Intensive plasmapheresis during pregnancy and spurious amniotic fluid bilirubin.
    Sussmann LN; Barias M; Colli W
    Am J Obstet Gynecol; 1979 Sep; 135(1):156-7. PubMed ID: 474648
    [No Abstract]   [Full Text] [Related]  

  • 72. [Foetomaternal erythrocyte incompatibilities: from immunohaematologic surveillance of pregnant women to haemolytic disease of the newborn].
    Miquel E; Cavelier B; Bonneau JC; Rouger P
    Transfus Clin Biol; 2005 Feb; 12(1):45-55. PubMed ID: 15814293
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Management of rhesus alloimmunization in pregnancy.
    Moise KJ
    Obstet Gynecol; 2002 Sep; 100(3):600-11. PubMed ID: 12220785
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Current management of hemolytic disease of the newborn infant.
    Naiman JL
    J Pediatr; 1972 Jun; 80(6):1049-59. PubMed ID: 4112666
    [No Abstract]   [Full Text] [Related]  

  • 75. [Kell antibodies in pregnancy].
    Rempen A; Schweppe KW
    Z Geburtshilfe Perinatol; 1983; 187(4):183-90. PubMed ID: 6684844
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Early plasmapheresis followed by high-dose γ-globulin treatment saved a severely Rho-incompatible pregnancy.
    Isojima S; Hisano M; Suzuki T; Sago H; Murashima A; Yamaguchi K
    J Clin Apher; 2011; 26(4):216-8. PubMed ID: 21506141
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Deviation in amniotic fluid optical density at a wavelength of 450 nm in Rh-immunized pregnancies from 14 to 40 weeks' gestation: a proposal for clinical management.
    Queenan JT; Tomai TP; Ural SH; King JC
    Am J Obstet Gynecol; 1993 May; 168(5):1370-6. PubMed ID: 8498414
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Maternal red blood cell alloimmunization requiring intrauterine transfusion: a comparative study on management and outcome depending on the type of antibody.
    Phung TV; Houfflin-Debarge V; Ramdane N; Ghesquière L; Delsalle A; Coulon C; Subtil D; Vaast P; Garabedian C
    Transfusion; 2018 May; 58(5):1199-1205. PubMed ID: 29512164
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Successful management of severe Kell alloimmunization in pregnancy with intravenous immune globulin.
    Patris M; Holoye A; Goldman D; De Coninck C; Colard M
    Transfus Apher Sci; 2024 Apr; 63(2):103868. PubMed ID: 38238203
    [TBL] [Abstract][Full Text] [Related]  

  • 80. First case of hemolytic disease of the newborn due to anti-Ula antibodies.
    Sakuma K; Suzuki H; Ohto H; Tsuneyama H; Uchikawa M
    Vox Sang; 1994; 66(4):293-4. PubMed ID: 8079454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.